Jochen Huber

Title: Jochen Huber: Innovator in Soluble Guanylate Cyclase Activators

Introduction

Jochen Huber is a notable inventor based in Mittelbiberach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of soluble guanylate cyclase (sGC) activators. With a total of 2 patents, his work focuses on innovative treatments for chronic liver diseases.

Latest Patents

Huber's latest patents include groundbreaking inventions aimed at treating portal hypertension. The first patent describes methods for treating patients with compensated cirrhosis by administering a therapeutically effective amount of a soluble guanylate cyclase activator or a pharmaceutically acceptable salt thereof. The second patent involves alkoxy pyrazoles as soluble guanylate cyclase activators, detailing compounds that can be used in the treatment of diseases such as Non-Alcoholic Steatohepatitis (NASH), cirrhosis, and portal hypertension.

Career Highlights

Jochen Huber is currently associated with Boehringer Ingelheim International GmbH, where he continues to advance his research and development efforts. His work has been instrumental in creating new therapeutic options for patients suffering from liver-related conditions.

Collaborations

Huber collaborates with esteemed colleagues, including Judith Maria Ertle and Ruediger Streicher, to further enhance the impact of his research in the pharmaceutical industry.

Conclusion

Jochen Huber's innovative work in the field of soluble guanylate cyclase activators showcases his commitment to improving patient outcomes in chronic liver diseases. His contributions are paving the way for new treatment options that can significantly benefit those in need.